Literature DB >> 25231094

On WHO's essential medicines process and transparency.

Nicola Magrini1, Jane Robertson2, Kees de Joncheere2, Lisa Bero3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231094     DOI: 10.1136/bmj.g5637

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  The case for an essential medicines list for Canada.

Authors:  Gina Eom; Paul Grootendorst; Jacalyn Duffin
Journal:  CMAJ       Date:  2016-06-13       Impact factor: 8.262

2.  Essential Medicines in a High Income Country: Essential to Whom?

Authors:  Mai Duong; Rebekah J Moles; Betty Chaar; Timothy F Chen
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

3.  Scientific Advisory Committees at the World Health Organization: A Qualitative Study of How Their Design Affects Quality, Relevance, and Legitimacy.

Authors:  Unni Gopinathan; Steven J Hoffman; Trygve Ottersen
Journal:  Glob Chall       Date:  2018-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.